ATE298230T1 - Verwendung einer sich an periphere benzodiazepinrezeptoren bindenden substanz zur behandlung von hautstress - Google Patents
Verwendung einer sich an periphere benzodiazepinrezeptoren bindenden substanz zur behandlung von hautstressInfo
- Publication number
- ATE298230T1 ATE298230T1 AT99972094T AT99972094T ATE298230T1 AT E298230 T1 ATE298230 T1 AT E298230T1 AT 99972094 T AT99972094 T AT 99972094T AT 99972094 T AT99972094 T AT 99972094T AT E298230 T1 ATE298230 T1 AT E298230T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- peripheral benzodiazepine
- substance binding
- benzodiazepine receptors
- skin stress
- Prior art date
Links
- 102000004300 GABA-A Receptors Human genes 0.000 title abstract 2
- 108090000839 GABA-A Receptors Proteins 0.000 title abstract 2
- 230000002093 peripheral effect Effects 0.000 title abstract 2
- 239000000126 substance Substances 0.000 title 1
- 239000003446 ligand Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9814387A FR2785803B1 (fr) | 1998-11-17 | 1998-11-17 | Utilisation d'une substance se liant au recepteur peripherique des benzodiazepines dans le traitement des stress cutanes |
PCT/FR1999/002761 WO2000028947A2 (fr) | 1998-11-17 | 1999-11-10 | Utilisation d'une substance se liant au recepteur peripherique des benzodiazepines dans le traitement des stress cutanes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE298230T1 true ATE298230T1 (de) | 2005-07-15 |
Family
ID=9532791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99972094T ATE298230T1 (de) | 1998-11-17 | 1999-11-10 | Verwendung einer sich an periphere benzodiazepinrezeptoren bindenden substanz zur behandlung von hautstress |
Country Status (18)
Country | Link |
---|---|
US (2) | US6767533B1 (de) |
EP (1) | EP1131039B1 (de) |
JP (1) | JP2002529486A (de) |
KR (1) | KR20010089475A (de) |
AT (1) | ATE298230T1 (de) |
AU (1) | AU764786B2 (de) |
CA (1) | CA2349919A1 (de) |
CY (1) | CY1105144T1 (de) |
DE (1) | DE69925928T2 (de) |
DK (1) | DK1131039T3 (de) |
ES (1) | ES2244246T3 (de) |
FR (1) | FR2785803B1 (de) |
HK (1) | HK1037966A1 (de) |
HR (1) | HRP20010367A2 (de) |
HU (1) | HUP0105058A2 (de) |
PT (1) | PT1131039E (de) |
SI (1) | SI1131039T1 (de) |
WO (1) | WO2000028947A2 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2246588T3 (es) * | 1998-12-18 | 2006-02-16 | Scios Inc. | Tratamiento de enfermedades que implican formacion de quistes. |
US20060025388A1 (en) * | 1999-04-30 | 2006-02-02 | Glick Gary D | Compositions and methods relating to novel compounds and targets thereof |
US7276348B2 (en) * | 1999-04-30 | 2007-10-02 | Regents Of The University Of Michigan | Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof |
US7572788B2 (en) * | 1999-04-30 | 2009-08-11 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
US20030119029A1 (en) * | 1999-04-30 | 2003-06-26 | Regents Of The University Of Michigan | Compositions and methods relating to novel benzodiazepine compounds and targets thereof |
US20040176358A1 (en) * | 1999-04-30 | 2004-09-09 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
US20050113460A1 (en) * | 1999-04-30 | 2005-05-26 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
ES2214273T3 (es) * | 1999-04-30 | 2004-09-16 | The Regents Of The University Of Michigan | Utilizacion de benzodiazepinas para el tratamiento de enfermedades autoinmunes inducidas por apoptosis. |
DE10021468A1 (de) * | 2000-05-04 | 2001-11-08 | Basf Ag | Verwendung von PARP-Inhibitoren in kosmetischen Zubereitungen |
BR0314595A (pt) | 2002-09-20 | 2005-08-09 | Arrow Therapeutics Ltd | Uso de um derivado de benzodiazepina ou um sal farmaceuticamente aceitável deste, inalador ou nebulisador, produto, usos de um produto e de um composto ou sal farmaceuticamente aceitável deste, derivado de benzodiazepina, composto, e, composição farmacêutica |
US20050272723A1 (en) * | 2004-04-27 | 2005-12-08 | The Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
US20060052369A1 (en) * | 2004-09-07 | 2006-03-09 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
FR2879450B1 (fr) * | 2004-12-20 | 2007-02-09 | Oreal | Antagonistes des recepteurs peripheriques des benzodiazepines pour le traitement des peaux seches |
FR2879451B1 (fr) * | 2004-12-20 | 2007-05-04 | Oreal | Utilisation de ligands du recepteur des benzodiazepines pour lutter contre les signes du vieillissement |
EP1830796A2 (de) * | 2004-12-20 | 2007-09-12 | L'Oréal | Verwendung von benzodiazepin-rezeptor-liganden zur bekämpfung der zeichen von alterung |
WO2006067327A2 (fr) * | 2004-12-20 | 2006-06-29 | L'oreal | Antagonistes des recepteurs peripheriques des benzodiazepines pour le traitement des peaux seches |
JP2008528448A (ja) | 2005-01-03 | 2008-07-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 新規化合物に関連する組成物および方法、ならびにその標的 |
JP2008545757A (ja) * | 2005-06-01 | 2008-12-18 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 溶媒和されていないベンゾジアゼピン組成物および方法 |
JP5241501B2 (ja) | 2005-11-01 | 2013-07-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 治療特性を有する新規の1,4−ベンゾジアゼピン−2,5−ジオン |
KR20070058291A (ko) * | 2005-12-02 | 2007-06-08 | 엘지전자 주식회사 | 기록매체, 기록매체의 관리정보 기록방법 및 기록장치 |
US7759338B2 (en) * | 2006-04-27 | 2010-07-20 | The Regents Of The University Of Michigan | Soluble 1,4 benzodiazepine compounds and stable salts thereof |
EP2037741B1 (de) | 2006-06-09 | 2013-11-27 | The Regents Of The University Of Michigan | Benzodiazepin-derivate zur behandlung von krankheiten auf immun-, inflammatorischer oder proliferativer basis |
EP2059813A2 (de) * | 2006-06-26 | 2009-05-20 | Technion Research & Development Foundation LTD. | Verfahren und kits zur krebsdiagnose |
EP2139331B1 (de) | 2007-03-09 | 2013-02-20 | The Regents of the University of Michigan | Zusammensetzungen und verfahren für neue verbindungen und ihre targets |
CN101842079B (zh) * | 2007-08-31 | 2012-09-05 | 阿基米德开发有限公司 | 非水性药物组合物 |
CN101855203B (zh) | 2007-09-14 | 2014-03-19 | 密执安州立大学董事会 | F1f0-atp合成酶抑制剂以及相关的方法 |
CA2703005A1 (en) | 2007-11-06 | 2009-05-14 | The Regents Of The University Of Michigan | Benzodiazepinone compounds useful in the treatment of skin conditions |
WO2010030891A2 (en) | 2008-09-11 | 2010-03-18 | The Regents Of The University Of Michigan | Aryl guanidine f1f0-atpase inhibitors and related methods |
WO2010121164A2 (en) | 2009-04-17 | 2010-10-21 | The Regents Of The University Of Michigan | 1,4-benzodiazepinone compounds and their use in treating cancer |
US9075060B2 (en) | 2009-06-16 | 2015-07-07 | Technion Research & Development Foundation Limited | Methods for diagnosing oral or oral-pharyngeal cancer |
US8673897B2 (en) | 2009-09-18 | 2014-03-18 | The Regents Of The University Of Michigan | Benzodiazepinone compounds and methods of treatment using same |
CA2915237C (en) | 2009-11-17 | 2017-10-10 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
JP5856064B2 (ja) | 2009-11-17 | 2016-02-09 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 治療特性を有する1,4−ベンゾジアゼピン−2,5−ジオンおよび関連化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5279082A (en) * | 1975-12-25 | 1977-07-02 | Green Cross Corp:The | Preparation of anti-tumor compound |
JPS5473195A (en) * | 1977-11-22 | 1979-06-12 | Takeda Chem Ind Ltd | Preparation of tomaymycins |
JPS56121495A (en) * | 1980-02-29 | 1981-09-24 | Kyowa Hakko Kogyo Co Ltd | Preparation of benzodiazepine derivative |
IL101387A (en) * | 1992-03-26 | 1999-11-30 | Pharmos Ltd | Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets |
ATE152630T1 (de) * | 1992-07-28 | 1997-05-15 | Procter & Gamble | Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält |
ES2214273T3 (es) * | 1999-04-30 | 2004-09-16 | The Regents Of The University Of Michigan | Utilizacion de benzodiazepinas para el tratamiento de enfermedades autoinmunes inducidas por apoptosis. |
-
1998
- 1998-11-17 FR FR9814387A patent/FR2785803B1/fr not_active Expired - Fee Related
-
1999
- 1999-11-10 EP EP99972094A patent/EP1131039B1/de not_active Expired - Lifetime
- 1999-11-10 PT PT99972094T patent/PT1131039E/pt unknown
- 1999-11-10 AT AT99972094T patent/ATE298230T1/de not_active IP Right Cessation
- 1999-11-10 ES ES99972094T patent/ES2244246T3/es not_active Expired - Lifetime
- 1999-11-10 KR KR1020017006238A patent/KR20010089475A/ko active IP Right Grant
- 1999-11-10 US US09/831,720 patent/US6767533B1/en not_active Expired - Fee Related
- 1999-11-10 JP JP2000581995A patent/JP2002529486A/ja not_active Withdrawn
- 1999-11-10 AU AU11661/00A patent/AU764786B2/en not_active Ceased
- 1999-11-10 SI SI9930814T patent/SI1131039T1/xx unknown
- 1999-11-10 DK DK99972094T patent/DK1131039T3/da active
- 1999-11-10 CA CA002349919A patent/CA2349919A1/en not_active Abandoned
- 1999-11-10 HU HU0105058A patent/HUP0105058A2/hu unknown
- 1999-11-10 DE DE69925928T patent/DE69925928T2/de not_active Expired - Fee Related
- 1999-11-10 WO PCT/FR1999/002761 patent/WO2000028947A2/fr not_active Application Discontinuation
-
2001
- 2001-05-17 HR HR20010367A patent/HRP20010367A2/hr not_active Application Discontinuation
- 2001-12-11 HK HK01108691A patent/HK1037966A1/xx not_active IP Right Cessation
-
2004
- 2004-07-26 US US10/898,793 patent/US20050090489A1/en not_active Abandoned
-
2005
- 2005-09-21 CY CY20051101175T patent/CY1105144T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002529486A (ja) | 2002-09-10 |
US6767533B1 (en) | 2004-07-27 |
WO2000028947A2 (fr) | 2000-05-25 |
AU1166100A (en) | 2000-06-05 |
SI1131039T1 (en) | 2005-10-31 |
FR2785803A1 (fr) | 2000-05-19 |
WO2000028947A3 (fr) | 2000-08-03 |
ES2244246T3 (es) | 2005-12-01 |
AU764786B2 (en) | 2003-08-28 |
EP1131039A2 (de) | 2001-09-12 |
US20050090489A1 (en) | 2005-04-28 |
DK1131039T3 (da) | 2005-10-17 |
CY1105144T1 (el) | 2010-03-03 |
FR2785803B1 (fr) | 2005-03-25 |
EP1131039B1 (de) | 2005-06-22 |
HRP20010367A2 (en) | 2002-06-30 |
DE69925928D1 (de) | 2005-07-28 |
HK1037966A1 (en) | 2002-03-01 |
CA2349919A1 (en) | 2000-05-25 |
KR20010089475A (ko) | 2001-10-06 |
DE69925928T2 (de) | 2006-08-17 |
HUP0105058A2 (hu) | 2002-05-29 |
PT1131039E (pt) | 2005-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE298230T1 (de) | Verwendung einer sich an periphere benzodiazepinrezeptoren bindenden substanz zur behandlung von hautstress | |
DE69816109D1 (de) | Substituierte imidazole zur behandlung von entzündlichen krankheiten | |
DE69822919D1 (de) | Spezifische Antikörper zur Verwendung in der Herstellung pharmazeutischer Zusammensetzungen nützlich für die Vorbeugung oder Behandlung von Gastritis, Magen- und Zwölffingerdarmgeschwüren | |
ATE256463T1 (de) | Pharmazeutische zubereitung zur verwendung in der behandlung von diabetes | |
ATE258919T1 (de) | Verwendung von alkylierten iminozuckern zur behandlung von multipler medikamentenresistenz | |
ATE200863T1 (de) | Indolinonverbindungen zur behandlung von krankheiten | |
ATA46794A (de) | Einrichtung zur behandlung von hautzonen | |
ATA69098A (de) | Stoffgemisch zur topischen anwendung | |
DE69737948D1 (de) | Vorrichtung zur rekonstruktion von sehnen | |
DE69609868D1 (de) | Neue steroidester zur behandlung von hauterkrankungen | |
DE3780972T2 (de) | Verwendung von spezifischen n-methyl-d-aspartat-rezeptor-antagonisten zur praevention und behandlung von neurodegeneration. | |
DE69634951D1 (de) | Topische verwendung von betulinsäure zur behandlung bösartiger melanome | |
DE69531941D1 (de) | Präparat zur haarbehandlung, das erst direkt vor der verwendung gemischt wird | |
EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
ATA76995A (de) | Stabiles präparat zur behandlung von blutgerinnungsstörungen | |
DE69518037T2 (de) | Klebstoffmischung für die Zahnbehandlung | |
DE69904922D1 (de) | Pharmazeutische zusammensetzung zur behandlung von alkoholabhängigkeit, die opioid antagonisten mit nmda-rezeptorkomplex-modulatoren enthält | |
DE59706572D1 (de) | Verwendung von carboxyamid-polysiloxanen zur lederhydrophobierung | |
GR3025698T3 (en) | NOVEL GABAa RECEPTOR SUBTYPES AND METHODS FOR SCREENING DRUG COMPOUNDS USING IMIDAZOQUINOXALINES AND PYRROLOPYRIMIDINES TO BIND TO GABAa RECEPTOR SUBTYPES. | |
ATE221763T1 (de) | Die verwendung von glyceryltriacetat zur behandlung von onychomykosen | |
ATE210447T1 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
DE69931487D1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
ATE209891T1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis | |
TR199700547A2 (xx) | N-asetonilbenzamid fungisitler. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1131039 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |